BioSpace News Archive

Deals

Effepharm Announced Acquisitions and New R&D Center Establishment

The group of R&D professionals are dedicated to contribute their skills and talents to Effepharm.

December 12, 2019
·
2 min read
Biotech Bay

Omada Health Selected for Express Scripts Industry-First Digital Health Formulary

Omada Health today announced that its digital care programs for Diabetes Prevention, Type 2 Diabetes, and Hypertension will be included on the Express Scripts Digital Health Formulary beginning in early 2020.

December 12, 2019
·
2 min read
Genetown

Arcadia.io MSSP ACO Customers Averaged $4.36 Million in Shared Savings Bonuses in 2018

Arcadia customers received 2.5x the average bonus of other MSSP ACOs in 2018

December 12, 2019
·
3 min read
Global Automated Breast Ultrasound Systems (ABUS) Market 2019-2023 | Evolving Opportunities With GE Healthcare and Hitachi, Ltd. | Technavio

Technavio has announced its latest market research report titled global automated breast ultrasound systems (ABUS) market 2019-2023

December 12, 2019
·
4 min read
CVS Health Launches Transform Oncology Care™ Program to Help Improve Patient Outcomes and Lower Overall Costs

CVS Health (NYSE: CVS) today announced Transform Oncology Care™, anchored on a first-of-its-kind precision medicine strategy for payors

December 12, 2019
·
5 min read
PANTHERx® Rare Pharmacy Selected by Alnylam Pharmaceuticals to Distribute GIVLAARI™ (givosiran)

PANTHERx® Rare Pharmacy announces that it has been selected by Alnylam Pharmaceuticals as a very limited distribution partner for the novel drug GIVLAARI™ (givosiran)

December 12, 2019
·
2 min read
Pharm Country

BioAegis Therapeutics Announces Publication: “Delayed Administration of Recombinant Plasma Gelsolin Improves Survival in a Murine Model of Severe Influenza”

BioAegis Therapeutics, Inc., a clinical stage company developing technology to address injurious inflammation while protecting immune function and vital organs in diseases driven by inflammation and infection, announces publication of new research findings with recombinant human plasma gelsolin in influenza.

December 12, 2019
·
4 min read
Policy

Shineco, Inc. Awarded Certificate from Trade & Association (Singapore) to Jointly Establish Industry Hemp Comprehensive Utilization Park in China

Shineco, Inc. announced that the Company, through its subsidiary Shineco China Hemp Technology Co., Ltd., has award an certificate from Trade & Association on November 29, 2019 to jointly establish industry hemp comprehensive utilization park in China.

December 12, 2019
·
3 min read